Dalia Mohamed

Background Serum CXCL10 is one of the chemokines that is strongly associated with systemic lupus erythematosus (SLE) and its related complications, particularly lupus nephritis (LN). Our study aimed to validate serum CXCL10 as a potential biomarker of LN and disease activity, and to assess its association with organ damage in Egyptian patients.

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Document Type : Research Articles Authors Dalia Mohamed Hemeda 1 Ahmed El-Mesery 1 Mie Ali Mohamed 2 Zeinab Mohammed Ahmed Gawesh 2 Waleed Elnahas 3 Mahmoud Abdel-Aziz Soliman 1 1 Department of Tropical Medicine, Mansoura University, Mansoura, Egypt. 2 Department of Pathology, Faculty of Medicine, Mansoura University, Egypt. 3 Department of Surgical Oncology, Oncology Center, Mansoura University, Mansoura, Egypt.